W. Cheng et al., EFFECTS OF CARDIOMYOPLASTY ON BIVENTRICULAR FUNCTION IN CANINE CHRONIC HEART-FAILURE, The Annals of thoracic surgery, 55(4), 1993, pp. 893-901
Dynamic cardiomyoplasty, the use of skeletal muscle to assist the hear
t, is a new therapy for the treatment of heart failure. However, the e
ffects of cardiomyoplasty on biventricular function and the synchrony
of ventricular contraction are not fully known. We assessed the effica
cy of latissimus dorsi muscle (LDM) dynamic cardiomyoplasty in a chron
ic model of biventricular failure. Five dogs received doxorubicin (1 m
g . kg-1 . wk-1) for up to 12 weeks to induce heart failure and then u
nderwent a biventricular cardiomyoplasty. After operation, the muscle
was progressively stimulated according to an established protocol. Whe
n training was complete (10 weeks), radionuclide ventriculographic and
catheterization data were obtained. Peak left ventricular (LV) systol
ic pressure and its first derivative were unchanged, whereas LV end-di
astolic pressure decreased slightly with LDM assistance (11.0 +/- 1.6
to 9.6 +/- 1.5 mm Hg; p < 0.05). Right ventricular (RV) systolic press
ure increased significantly with LDM assistance from 21 +/- 2 to 26 +/
- 3 mm Hg (p < 0.05), whereas its first derivative and RV end-diastoli
c pressure were unchanged. Dynamic cardiomyoplasty significantly impro
ved LV ejection fraction from 0.18 +/- 0.07 without LDM assistance to
0.31 +/- 0.05 with LDM assistance (p < 0.05); similarly RV ejection fr
action increased from 0.32 +/- 0.07 to 0.45 +/- 0.06 with LDM assistan
ce (p < 0.05). The temporal sequence of LV wall motion was assessed by
phase analysis of the radionuclide ventriculograms. With skeletal mus
cle assistance, standard deviation (''spread'') decreased from 31.6 +/
- 17.4 to 20.0 +/- 15.4 degrees (p < 0.06), whereas skewness (''symmet
ry'') was unchanged. Dynamic cardiomyoplasty improved both LV and RV e
jection fractions without increasing diastolic pressure. Phase analysi
s demonstrated that the left ventricle contracted more synchronously,
adding support to the use of this new modality in treating the failing
heart.